Narayana Hrudayalaya Limited NH.NS Open Narayana Hrudayalaya Limited in new tab
Narayana Hrudayalaya Limited Analysis (NH.NS)
Is Narayana Hrudayalaya Limited a good investment? Narayana Hrudayalaya Limited (NH.NS) is currently trading at 1625.00 INR. Market analysts have a consensus price target of 2067.55 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 42.34. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Narayana Hrudayalaya Limited is expected to release its next earnings report on May 21, 2026. The market consensus estimate for Forward EPS is 57.19.
For income investors, Narayana Hrudayalaya Limited pays a dividend yield of 0.27%. With a payout ratio of 12%, the dividend appears sustainable.
Investor FAQ
Does Narayana Hrudayalaya Limited pay a dividend?
Yes, it pays an annual dividend of 4.50 INR (0.27% yield).
What asset class is Narayana Hrudayalaya Limited?
Narayana Hrudayalaya Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be May 21, 2026. The company currently has a trailing EPS of 38.27.
Company Profile
Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, ultrasonology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. Narayana Hrudayalaya Limited was incorporated in 2000 and is headquartered in Bengaluru, India.
Dividend Yield
0.27%
Annual Dividends
4.50 INR
Next ex. div date
Aug. 1, 2025
Payout Ratio
11.75%
Historical Dividends
| Year | Total Dividends |
|---|---|
| 2026 | 9.23 INR |
| Sept. 29, 2026 (estimated) | 9.2250 |
| 2025 | 4.50 INR |
| Sept. 28, 2025 | 4.5000 |
| 2024 | 4.00 INR |
| Sept. 29, 2024 | 4.0000 |
| 2023 | 2.50 INR |
| Sept. 3, 2023 | 2.5000 |
| 2022 | 1.00 INR |
| Sept. 29, 2022 | 1.0000 |
| 2020 | 1.00 INR |
| March 18, 2020 | 1.0000 |
| 2019 | 1.00 INR |
| Sept. 9, 2019 | 1.0000 |
Yearly aggregated dividends
Dividends
|
Narayana Hrudayalaya Limited
Sep 28, 2025 Paid
Dividend
4.5 INR |
Historical Split Corporate Actions
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion